Search

everythinglearnresearchcommunity

for

Search:↓

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Chemotherapy damages hair follicles, causing hair loss and other cellular changes.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Telomere damage affects skin and hair follicle stem cells by messing up important growth signals.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Baby teeth stem cells can potentially grow organs and treat diseases.

Advancements in tissue engineering show promise for hair follicle regeneration to treat hair loss.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

A 6-year-old boy developed excessive hair growth after taking diazoxide for low blood sugar.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Natural products in cosmetics are beneficial for skin and hair care with low toxicity.

FOXN1 gene variants cause low T cells and immune issues from birth.

Most patients with Porphyria Cutanea Tarda had skin blisters and were often affected by hepatitis C and alcohol abuse, with differences between familial and sporadic cases.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Pigs without the Hairless gene showed skin and thymus changes, useful for studying human hair disorders.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The method safely and efficiently delivers genes to the skin but may not work for conditions needing high levels of gene products.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.